البحث عن طبيب

Neil M. Ampel, M.D.

  1. Infectious Disease Specialist
  2. Internist

المنشورات

  1. Shah PJ, Ampel NM, Girardo ME, Blair JE. Serologic Rebound after Stopping Azoles for Primary Pulmonary Coccidioidomycosis: A Case-Controlled Observational Study. J Fungi (Basel). 2023 Sep 1; 9 (9) Epub 2023 Sept 01
    View PubMed
  2. Anwar F, Roxas BAP, Shehab KW, Ampel NM, Viswanathan VK, Vedantam G. Low-toxin Clostridioides difficile RT027 strains exhibit robust virulence. Emerg Microbes Infect. 2022 Dec; 11 (1):1982-1993
    View PubMed
  3. Gupta S, Ampel NM, Klanderman M, Grill MF, Blair JE. Fluconazole Failure in the Treatment of Coccidioidal Meningitis. J Fungi (Basel). 2022 Nov 1; 8 (11) Epub 2022 Nov 01
    View PubMed
  4. Thompson GR, Ampel NM, Blair JE, Donovan F, Fierer J, Galgiani JN, Heidari A, Johnson R, Shatsky SA, Uchiyama CM, Stevens DA. Controversies in the Management of Central Nervous System Coccidioidomycosis. Clin Infect Dis. 2022 Sep 10; 75 (4):555-559
    View PubMed
  5. Ashcherkin N, Gupta S, Huff DA, Vikram HR, Ampel NM, Fischer KM, Blair JE. Impact of COVID-19 on diagnosis of primary pulmonary coccidioidomycosis. Medicine (Baltimore). 2022 Sep 2; 101 (35):e30361
    View PubMed
  6. O'Shaughnessy E, Yasinskaya Y, Dixon C, Higgins K, Moore J, Reynolds K, Ampel NM, Angulo D, Blair JE, Catanzaro A, Galgiani JN, Garvey E, Johnson R, Larwood DJ, Lewis G, Purdie R, Rex JH, Shubitz LF, Stevens DA, Page SJ, Shukla SJ, Farley JJ, Nambiar S. FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs. Clin Infect Dis. 2022 Jun 10; 74 (11):2061-2066
    View PubMed
  7. Huff D, Ampel NM, Blair JE. Coccidioidomycosis and COVID-19 Infection. An Analysis from a Single Medical Center Within the Coccidioidal Endemic Area. Mycopathologia. 2022 Jun; 187 (2-3):199-204 Epub 2022 Apr 15
    View PubMed
  8. Thompson GR 3rd, Le T, Chindamporn A, Kauffman CA, Alastruey-Izquierdo A, Ampel NM, Andes DR, Armstrong-James D, Ayanlowo O, Baddley JW, Barker BM, Lopes Bezerra L, Buitrago MJ, Chamani-Tabriz L, Chan JFW, Chayakulkeeree M, Cornely OA, Cunwei C, Gangneux JP, Govender NP, Hagen F, Hedayati MT, Hohl TM, Jouvion G, Kenyon C, Kibbler CC, Klimko N, Kong DCM, Krause R, Lee Lee L, Meintjes G, Miceli MH, Rath PM, Spec A, Queiroz-Telles F, Variava E, Verweij PE, Schwartz IS, Pasqualotto AC. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec; 21 (12):e364-e374 Epub 2021 Aug 06
    View PubMed
  9. Panicker RR, Bartels HC, Gotway MB, Ampel NM, Buras MR, Lim ES, Blair JE. Cavitary Coccidioidomycosis: Impact of azole antifungal therapy. Med Mycol. 2021 Jul 14; 59 (8):834-841
    View PubMed
  10. Kusne Y, Kimes KE, Feller FF, Patron R, Banacloche JG, Blair JE, Vikram HR, Ampel NM. Coccidioidomycosis in Patients Treated With Ruxolitinib. Open Forum Infect Dis. 2020 Jun; 7 (6):ofaa167 Epub 2020 May 19
    View PubMed
  11. Galgiani JN, Blair JE, Ampel NM, Thompson GR. Treatment for Early, Uncomplicated Coccidioidomycosis: What Is Success? Clin Infect Dis. 2020 Apr 15; 70 (9):2008-2012
    View PubMed
  12. Jackson NR, Blair JE, Ampel NM. Central Nervous System Infections Due to Coccidioidomycosis. J Fungi (Basel). 2019 Jun 28; 5 (3) Epub 2019 June 28
    View PubMed
  13. Mafi N, Yaglom HD, Levy C, Taylor A, O'Grady C, Venkat H, Komatsu KK, Roller B, Seville MT, Kusne S, Po JL, Thorn S, Ampel NM. Tick-Borne Relapsing Fever in the White Mountains, Arizona, USA, 2013-2018. Emerg Infect Dis. 2019 Apr; 25 (4):649-653
    View PubMed
  14. Blair JE, Ampel NM, Hoover SE. Coccidioidomycosis in selected immunosuppressed hosts. Med Mycol. 2019 Feb 1; 57 (Supplement_1):S56-S63
    View PubMed
  15. Chaudhary S, Meinke L, Ateeli H, Knox KS, Raz Y, Ampel NM. Coccidioidomycosis among persons undergoing lung transplantation in the coccidioidal endemic region. Transpl Infect Dis. 2017 Apr 28;
    View PubMed
  16. Malo J, Holbrook E, Zangeneh T, Strawter C, Oren E, Robey I, Erickson H, Chahal R, Durkin M, Thompson C, Hoover SE, Ampel NM, Wheat LJ, Knox KS. Enhanced Antibody Detection and Diagnosis of Coccidioidomycosis with the MiraVista IgG and IgM Detection Enzyme Immunoassay. J Clin Microbiol. 2017 Mar; 55: (3)893-901.
    View PubMed
  17. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, Johnson RH, Kusne S, Lisse J, MacDonald JD, Meyerson SL, Raksin PB, Siever J, Stevens DA, Sunenshine R, Theodore N. 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. Clin Infect Dis. 2016 Sep 15; 63 (6):e112-46 Epub 2016 July 27
    View PubMed
  18. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, Johnson RH, Kusne S, Lisse J, MacDonald JD, Meyerson SL, Raksin PB, Siever J, Stevens DA, Sunenshine R, Theodore N. Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. Clin Infect Dis. 2016 Sep 15; 63 (6):717-22
    View PubMed
  19. Goel K, Ateeli H, Ampel NM, L'heureux D. Patient with Small Cell Lung Carcinoma and Suspected Right Upper Lobe Abscess Presenting with a Purulent Pericardial Effusion. Am J Case Rep. 2016 Jul 22; 17:523-8.
    View PubMed
  20. Pasha AK, Walsh TK, Ampel NM. Dual-Time-Point FDG PETCT to Distinguish Coccidioidal Pulmonary Nodules from Those Due to Malignancy. Lung. 2015 Oct; 193: (5)863-4.
    View PubMed
  21. Wack EE, Ampel NM, Sunenshine RH, Galgiani JN. The Return of Delayed-Type Hypersensitivity Skin Testing for Coccidioidomycosis. Clin Infect Dis. 2015 Sep 1; 61 (5):787-91 Epub 2015 May 15
    View PubMed
  22. Ampel NM. THE TREATMENT OF COCCIDIOIDOMYCOSIS. Rev Inst Med Trop Sao Paulo. 2015 Sep; 57 Suppl 19:51-6.
    View PubMed
  23. Ampel NM, Nesbit LA, Nguyen CT, Chavez S, Knox KS, Johnson SM, Pappagianis D. Cytokine Profiles from Antigen-Stimulated Whole-Blood Samples among Patients with Pulmonary or Nonmeningeal Disseminated Coccidioidomycosis. Clin Vaccine Immunol. 2015 Aug; 22: (8)917-22.
    View PubMed
  24. Reyes N, Onadeko OO, Luraschi-Monjagatta, Knox KS, Rennels MA, Walsh TK, Ampel NM. Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region. Lung. 2014 Aug; 192: (4)589-93.
    View PubMed
  25. Nesbit LA, Knox KS, Nguyen CT, Roesch J, Wheat LJ, Johnson SM, Pappagianis D, Chavez S, Ampel NM. Immunological characterization of bronchoalveolar lavage fluid in patients with acute pulmonary coccidioidomycosis. J Infect Dis. 2013 Sep 01; 208: (5)857-63.
    View PubMed
  26. Nguyen C, Barker BM, Hoover S, Nix DE, Ampel NM, Frelinger JA, Orbach MJ, Galgiani JN. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis. Clin Microbiol Rev. 2013 Jul; 26: (3)505-25.
    View PubMed
  27. Johnson R, Kernerman SM, Sawtelle BG, Rastogi SC, Nielsen HS, Ampel NM. A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis. Mycopathologia. 2012 Dec; 174: (5-6)353-8.
    View PubMed
  28. Taroumian S, Knowles SL, Lisse JR, Yanes J, Ampel NM, Vaz A, Galgiani JN, Hoover SE. Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs. Arthritis Care Res (Hoboken). 2012 Dec; 64: (12)1903-9.
    View PubMed
  29. Bercovitch RS, Catanzaro A, Schwartz BS, Pappagianis D, Watts DH, Ampel NM. Coccidioidomycosis during pregnancy: a review and recommendations for management. Clin Infect Dis. 2011 Aug; 53: (4)363-8.
    View PubMed
  30. Limper AH, Knox KS, Sarosi GA, Ampel NM, Bennett JE, Catanzaro A, Davies SF, Dismukes WE, Hage CA, Marr KA, Mody CH, Perfect JR, Stevens DA, American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 01; 183: (1)96-128.
    View PubMed
  31. Ampel NM. New perspectives on coccidioidomycosis. Proc Am Thorac Soc. 2010 May; 7: (3)181-5.
    View PubMed
  32. Ampel NM. What's Behind the Increasing Rates of Coccidioidomycosis in Arizona and California? Curr Infect Dis Rep. 2010 May; 12: (3)211-6.
    View PubMed
  33. Ampel NM. The diagnosis of coccidioidomycosis. F1000 Med Rep. 2010 Jan 18; 2:
    View PubMed
  34. Nesbit L, Johnson SM, Pappagianis D, Ampel NM. Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells. Infect Immun. 2010 Jan; 78: (1)309-15.
    View PubMed
  35. Masannat FY, Ampel NM. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis. 2010 Jan 01; 50: (1)1-7.
    View PubMed
  36. Ampel NM. Coccidioidomycosis: a review of recent advances. Clin Chest Med. 2009 Jun; 30: (2)241-51, v.
    View PubMed
  37. Ampel NM, Dionne SO, Giblin A, Podany AB, Galgiani J. Mannose-binding lectin serum levels are low in persons with clinically active coccidioidomycosis. Mycopathologia. 2009 Apr; 167: (4)173-80.
    View PubMed
  38. Ampel NM, Giblin A, Mourani JP, Galgiani JN. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. Clin Infect Dis. 2009 Jan 15; 48: (2)172-8.
    View PubMed
  39. Ampel NM. Coccidioidomycosis in persons infected with HIV-1. Ann N Y Acad Sci. 2007 Sep; 1111:336-42.
    View PubMed
  40. Ampel NM. The complex immunology of human coccidioidomycosis. Ann N Y Acad Sci. 2007 Sep; 1111:245-58.
    View PubMed
  41. Muir Bowers J, Mourani JP, Ampel NM. Fatigue in coccidioidomycosis. Quantification and correlation with clinical, immunological, and nutritional factors. Med Mycol. 2006 Nov; 44: (7)585-90.
    View PubMed
  42. Valdivia L, Nix D, Wright M, Lindberg E, Fagan T, Lieberman D, Stoffer T, Ampel NM, Galgiani JN. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis. 2006 Jun; 12: (6)958-62.
    View PubMed
  43. Dionne SO, Podany AB, Ruiz YW, Ampel NM, Galgiani JN, Lake DF. Spherules derived from Coccidioides posadasii promote human dendritic cell maturation and activation. Infect Immun. 2006 Apr; 74: (4)2415-22.
    View PubMed
  44. Ampel NM, Hector RF, Lindan CP, Rutherford GW. An archived lot of coccidioidin induces specific coccidioidal delayed-type hypersensitivity and correlates with in vitro assays of coccidioidal cellular immune response. Mycopathologia. 2006 Feb; 161: (2)67-72.
    View PubMed
  45. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA, Williams PL, Infectious Diseases Society of America. Coccidioidomycosis. Clin Infect Dis. 2005 Nov 01; 41: (9)1217-23.
    View PubMed
  46. Ampel NM. Coccidioidomycosis in persons infected with HIV type 1. Clin Infect Dis. 2005 Oct 15; 41: (8)1174-8.
    View PubMed
  47. Li L, Dial SM, Schmelz M, Rennels MA, Ampel NM. Cellular immune suppressor activity resides in lymphocyte cell clusters adjacent to granulomata in human coccidioidomycosis. Infect Immun. 2005 Jul; 73 (7):3923-8
    View PubMed
  48. Ampel NM, Nelson DK, Chavez S, Naus KA, Herman AB, Li L, Simmons KA, Pappagianis D. Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis. Clin Diagn Lab Immunol. 2005 Jun; 12 (6):700-4
    View PubMed
  49. Ampel NM, Nelson DK, Li L, Dionne SO, Lake DF, Simmons KA, Pappagianis D. The mannose receptor mediates the cellular immune response in human coccidioidomycosis. Infect Immun. 2005 Apr; 73 (4):2554-5
    View PubMed
  50. Bergstrom L, Yocum DE, Ampel NM, Villanueva I, Lisse J, Gluck O, Tesser J, Posever J, Miller M, Araujo J, Kageyama DM, Berry M, Karl L, Yung CM. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum. 2004 Jun; 50 (6):1959-66
    View PubMed
  51. Ampel NM. Combating opportunistic infections: coccidioidomycosis. Expert Opin Pharmacother. 2004 Feb; 5 (2):255-61
    View PubMed
  52. Ampel NM, Kramer LA. In vitro modulation of cytokine production by lymphocytes in human coccidioidomycosis. Cell Immunol. 2003 Feb; 221 (2):115-21
    View PubMed
  53. Ampel NM. Measurement of cellular immunity in human coccidioidomycosis. Mycopathologia. 2003; 156 (4):247-62
    View PubMed
  54. Ampel NM, Kramer LA, Li L, Carroll DS, Kerekes KM, Johnson SM, Pappagianis D. In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K. Clin Diagn Lab Immunol. 2002 Sep; 9 (5):1039-43
    View PubMed
  55. Richards JO, Ampel NM, Lake DF. Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis. J Immunol. 2002 Aug 15; 169 (4):2020-5
    View PubMed
  56. Richards JO, Ampel NM, Galgiani JN, Lake DF. Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation. J Infect Dis. 2001 Nov 01; 184 (9):1220-4 Epub 2001 Sept 19
    View PubMed
  57. Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001 Sep; 35 (9):1010-5
    View PubMed
  58. Ampel NM, Kramer LA, Kerekes KM, Johnson SM, Pappagianis D. Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood. Med Mycol. 2001 Aug; 39 (4):315-20
    View PubMed
  59. Leake JA, Mosley DG, England B, Graham JV, Plikaytis BD, Ampel NM, Perkins BA, Hajjeh RA. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis. 2000 Apr; 181 (4):1435-40 Epub 2000 Apr 07
    View PubMed
  60. Woods CW, McRill C, Plikaytis BD, Rosenstein NE, Mosley D, Boyd D, England B, Perkins BA, Ampel NM, Hajjeh RA. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis. 2000 Apr; 181 (4):1428-34 Epub 2000 Apr 07
    View PubMed
  61. Ampel NM, Christian L. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen. Med Mycol. 2000 Apr; 38 (2):127-32
    View PubMed
  62. Hung CY, Ampel NM, Christian L, Seshan KR, Cole GT. A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses. Infect Immun. 2000 Feb; 68 (2):584-93
    View PubMed
  63. Ampel NM. Delayed-type hypersensitivity, in vitro T-cell responsiveness and risk of active coccidioidomycosis among HIV-infected patients living in the coccidioidal endemic area. Med Mycol. 1999 Aug; 37 (4):245-50
    View PubMed
  64. Polesky A, Kirsch CM, Snyder LS, LoBue P, Kagawa FT, Dykstra BJ, Wehner JH, Catanzaro A, Ampel NM, Stevens DA. Airway coccidioidomycosis--report of cases and review. Clin Infect Dis. 1999 Jun; 28 (6):1273-80
    View PubMed
  65. Ampel NM, Mosley DG, England B, Vertz PD, Komatsu K, Hajjeh RA. Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. Clin Infect Dis. 1998 Dec; 27 (6):1528-30
    View PubMed
  66. Pear SM, Goldsmith DL, Williamson TH, Mandel D, Sethi GK, Arzouman DA, Ampel NM. Identification and voluntary reduction of vancomycin use for perioperative antibiotic prophylaxis during coronary artery bypass graft surgery. Infect Control Hosp Epidemiol. 1998 Jul; 19 (7):513-5
    View PubMed
  67. Rynkiewicz DL, Cage GD, Butler WR, Ampel NM. Clinical and microbiological assessment of Mycobacterium simiae isolates from a single laboratory in southern Arizona. Clin Infect Dis. 1998 Mar; 26 (3):625-30
    View PubMed
  68. Ampel NM, Christian L. In vitro modulation of proliferation and cytokine production by human peripheral blood mononuclear cells from subjects with various forms of coccidioidomycosis. Infect Immun. 1997 Nov; 65 (11):4483-7
    View PubMed
  69. Clark DR, Ampel NM, Hallett CA, Yedavalli VR, Ahmad N, DeLuca D. Peripheral blood from human immunodeficiency virus type 1-infected patients displays diminished T cell generation capacity. J Infect Dis. 1997 Sep; 176 (3):649-54
    View PubMed
  70. Marchalonis JJ, Ampel NM, Schluter SF, Garza A, Lake DF, Galgiani JN, Landsperger WJ. Analysis of autoantibodies to T-cell receptors among HIV-infected individuals: epitope analysis and time course. Clin Immunol Immunopathol. 1997 Feb; 82 (2):174-89
    View PubMed
  71. Bowers JM, Scott RW, Ampel NM. Comparison of resting energy expenditure measured by indirect calorimetry and the Harris-Benedict equation in HIV-infected men of normal body weight. Respir Care .1997;42:1018-21.
  72. Corry DB, Ampel NM, Christian L, Locksley RM, Galgiani JN. Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. J Infect Dis. 1996 Aug; 174 (2):440-3
    View PubMed
  73. Copfer AE, Ampel NM, Hughes TE, Gregor KJ, Dols CL, Coons SJ, Colgan K, Wu AW. The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparison. Qual Life Res. 1996 Apr; 5 (2):281-6
    View PubMed
  74. Ampel NM, Ahmann DR, Delgado KL, Galgiani JN, Cloud GA. Tumor necrosis factor-alpha and interleukin-1 beta in cerebrospinal fluid of patients with coccidioidal meningitis during therapy with fluconazole. National Institute of Allergy and Infectious Diseases Mycoses Study Group. J Infect Dis. 1995 Jun; 171 (6):1675-8
    View PubMed
  75. Arguinchona HL, Ampel NM, Dols CL, Galgiani JN, Mohler MJ, Fish DG. Persistent coccidioidal seropositivity without clinical evidence of active coccidioidomycosis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1995 May; 20 (5):1281-5
    View PubMed
  76. Marchalonis JJ, Lake DF, Schluter SF, Dehghanpisheh K, Watson RR, Ampel NM, Galgiani JN. Autoantibodies against peptide-defined epitopes of T-cell receptors in retrovirally infected humans and mice. Adv Exp Med Biol. 1995; 383:211-22
    View PubMed
  77. DiTomasso JP, Ampel NM, Sobonya RE, Bloom JW. Bronchoscopic diagnosis of pulmonary coccidioidomycosis. Comparison of cytology, culture, and transbronchial biopsy. Diagn Microbiol Infect Dis. 1994 Feb; 18 (2):83-7
    View PubMed
  78. Ampel NM. In vitro production of tumor necrosis factor-alpha by adherent human peripheral blood mononuclear cells incubated with killed coccidioidal arthroconidia and spherules. Cell Immunol. 1994 Jan; 153 (1):248-55
    View PubMed
  79. Lopez AM, Williams PL, Ampel NM. Acute pulmonary coccidioidomycosis mimicking bacterial pneumonia and septic shock: a report of two cases. Am J Med. 1993 Aug; 95 (2):236-9
    View PubMed
  80. Mahaffey KW, Hippenmeyer CL, Mandel R, Ampel NM. Unrecognized coccidioidomycosis complicating Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus and treated with corticosteroids. A report of two cases. Arch Intern Med. 1993 Jun 28; 153 (12):1496-8
    View PubMed
  81. Neumayer LA, Makar R, Ampel NM, Zukoski CF. Cytomegalovirus appendicitis in a patient with human immunodeficiency virus infection. Case report and review of the literature. Arch Surg. 1993 Apr; 128 (4):467-8
    View PubMed
  82. Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med. 1993 Mar; 94 (3):235-40
    View PubMed
  83. Ampel NM, Bejarano GC, Galgiani JN. Killing of Coccidioides immitis by human peripheral blood mononuclear cells. Infect Immun. 1992 Oct; 60 (10):4200-4
    View PubMed
  84. Galgiani JN, Sun SH, Dugger KO, Ampel NM, Grace GG, Harrison J, Wieden MA. An arthroconidial-spherule antigen of Coccidioides immitis: differential expression during in vitro fungal development and evidence for humoral response in humans after infection or vaccination. Infect Immun. 1992 Jul; 60 (7):2627-35
    View PubMed
  85. Ampel NM, Bejarano GC, Salas SD, Galgiani JN. In vitro assessment of cellular immunity in human coccidioidomycosis: relationship between dermal hypersensitivity, lymphocyte transformation, and lymphokine production by peripheral blood mononuclear cells from healthy adults. J Infect Dis. 1992 Apr; 165 (4):710-5
    View PubMed
  86. Garewal HS, Ampel NM, Watson RR, Prabhala RH, Dols CL. A preliminary trial of beta-carotene in subjects infected with the human immunodeficiency virus. J Nutr. 1992 Mar; 122 (3 Suppl):728-32
    View PubMed
  87. Ampel NM, Bejarano GC, Saavedra M Jr. Deferoxamine increases the susceptibility of beta-thalassemic, iron-overloaded mice to infection with Listeria monocytogenes. Life Sci. 1992; 50 (18):1327-32
    View PubMed
  88. Ampel NM. Plagues--what's past is present: thoughts on the origin and history of new infectious diseases. Rev Infect Dis. 1991 Jul-Aug; 13 (4):658-65
    View PubMed
  89. Dugger KO, Galgiani JN, Ampel NM, Sun SH, Magee DM, Harrison J, Law JH. An immunoreactive apoglycoprotein purified from Coccidioides immitis. Infect Immun. 1991 Jul; 59 (7):2245-51
    View PubMed
  90. Ampel NM, Galgiani JN. Interaction of human peripheral blood mononuclear cells with Coccidioides immitis arthroconidia. Cell Immunol. 1991 Mar; 133 (1):253-62
    View PubMed
  91. Fish DG, Ampel NM, Galgiani JN, Dols CL, Kelly PC, Johnson CH, Pappagianis D, Edwards JE, Wasserman RB, Clark RJ. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore). 1990 Nov; 69 (6):384-91
    View PubMed
  92. Ampel NM, Stout ML, Garewal HS, Davis JR. Persistent rectal ulcer associated with human papillomavirus type 33 in a patient with AIDS: successful treatment with isotretinoin. Rev Infect Dis. 1990 Nov-Dec; 12 (6):1004-7
    View PubMed
  93. Ampel NM, Wieden MA, Galgiani JN. Coccidioidomycosis: clinical update. Rev Infect Dis. 1989 Nov-Dec; 11 (6):897-911
    View PubMed
  94. Ampel NM, Van Wyck DB, Aguirre ML, Willis DG, Popp RA. Resistance to infection in murine beta-thalassemia. Infect Immun. 1989 Apr; 57 (4):1011-7
    View PubMed
  95. Galgiani JN, Dugger KO, Ampel NM, Sun SH, Law JH. Extraction of serologic and delayed hypersensitivity antigens from spherules of Coccidioides immitis. Diagn Microbiol Infect Dis. 1988 Oct; 11 (2):65-80
    View PubMed
  96. Wack EE, Ampel NM, Galgiani JN, Bronnimann DA. Coccidioidomycosis during pregnancy. An analysis of ten cases among 47,120 pregnancies. Chest. 1988 Aug; 94 (2):376-9
    View PubMed
  97. Ampel NM, White JD, Varanasi UR, Larwood TR, Van Wyck DB, Galgiani JN. Coccidioidal peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1988 Jun; 11 (6):512-4
    View PubMed
  98. Perlman DM, Ampel NM, Schifman RB, Cohn DL, Patton CM, Aguirre ML, Wang WL, Blaser MJ. Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV). Ann Intern Med. 1988 Apr; 108 (4):540-6
    View PubMed
  99. Parides GC, Bloom JW, Ampel NM, Ray CG. Mycoplasma and ureaplasma in bronchoalveolar lavage fluids from immunocompromised hosts. Diagn Microbiol Infect Dis. 1988 Jan; 9 (1):55-7
    View PubMed
  100. Ampel NM, Wieden MA. Discrepancy between growth of Coccidioides immitis in bacterial blood culture media and a radiometric growth index. Diagn Microbiol Infect Dis. 1988 Jan; 9 (1):7-10
    View PubMed
  101. Magee DM, Wing EJ, Ampel NM, Waheed A, Shadduck RK. Macrophage colony-stimulating factor enhances the expression of Fc receptors on murine peritoneal macrophages. Immunology. 1987 Nov; 62 (3):373-8
    View PubMed
  102. Ampel NM, Labadie EL. Chemotherapy for bacterial infections of the central nervous system. West J Med. 1987 Sep; 147 (3):309-13
    View PubMed
  103. Ampel NM, Ryan KJ, Carry PJ, Wieden MA, Schifman RB. Fungemia due to Coccidioides immitis. An analysis of 16 episodes in 15 patients and a review of the literature. Medicine (Baltimore). 1986 Sep; 65 (5):312-21
    View PubMed
  104. Thacker WL, Benson RF, Wilkinson HW, Ampel NM, Wing EJ, Steigerwalt AG, Brenner DJ. 11th serogroup of Legionella pneumophila isolated from a patient with fatal pneumonia. J Clin Microbiol. 1986 Jun; 23 (6):1146-7
    View PubMed
  105. Ampel NM, Wing EJ, Waheed A, Shadduck RK. Stimulatory effects of purified macrophage colony-stimulating factor on murine resident peritoneal macrophages. Cell Immunol. 1986 Feb; 97 (2):344-56
    View PubMed
  106. Wilkinson HW, Thacker WL, Steigerwalt AG, Brenner DJ, Ampel NM, Wing EJ. Second serogroup of Legionella hackeliae isolated from a patient with pneumonia. J Clin Microbiol. 1985 Oct; 22 (4):488-9
    View PubMed
  107. Wing EJ, Ampel NM, Waheed A, Shadduck RK. Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J Immunol. 1985 Sep; 135 (3):2052-6
    View PubMed
  108. Ampel NM, Ruben FL, Norden CW. Cutaneous abscess caused by Legionella micdadei in an immunosuppressed patient. Ann Intern Med. 1985 May; 102 (5):630-2
    View PubMed
  109. Ampel NM, Keating MH, Moon-McDermott L, Peter G, Zinner SH. Comparison of tube dilution and microtitre methods for the detection of antibiotic tolerance in strains of Staphylococcus aureus. J Antimicrob Chemother. 1984 May; 13 (5):417-21
    View PubMed